FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2520829703> ?p ?o ?g. }

• W2520829703 abstract "Clozapine is an effective treatment for a proportion of people with schizophrenia (SZ) who are resistant to the beneficial effects of other antipsychotic drugs. However, anything from 40–60 % of people on clozapine experience residual symptoms even on adequate doses of the medication, and thus could be considered ‘clozapine resistant’. Agents that could work alongside clozapine to improve efficacy whilst not increasing the adverse effect burden are both desired and necessary to improve the lives of individuals with clozapine-resistant SZ. N-Acetylcysteine (NAC) is one such possible agent. Previous research from our research group provided promising pilot data suggesting the efficacy of NAC in this patient population. The aim of the study reported here is to expand this work by conducting a large scale clinical trial of NAC in the treatment of clozapine-resistant SZ. This study is an investigator initiated, multi-site, randomised, placebo-controlled trial. It aims to include 168 patients with clozapine-resistant SZ, divided into an intervention group (NAC) and a control group (placebo). Participants in the intervention group will receive 2 g daily of NAC. The primary outcome measures will be the negative symptom scores of the Positive and Negative Syndrome Scale (PANSS). Secondary outcome measures will include: changes in quality of life (QoL) as measured by the Lancashire Quality of Life Profile (LQoLP) and cognitive functioning as measured by the total score on the MATRICS. Additionally we will examine peripheral and cortical glutathione (GSH) concentrations as process outcomes. This large scale clinical trial will investigate the efficacy of NAC as an adjunctive medication to clozapine. This trial, if successful, will establish a cheap, safe and easy-to-use agent (NAC) as a ‘go to’ adjunct in patients that are only partly responsive to clozapine. Australian and New Zealand Clinical Trials Registration Number: Current Randomised Controlled Trial ACTRN12615001273572 . The date of registration 23 November 2015." @default.
• W2520829703 created "2016-09-23" @default.
• W2520829703 creator A5001271340 @default.
• W2520829703 creator A5013936218 @default.
• W2520829703 creator A5022628011 @default.
• W2520829703 creator A5028782037 @default.
• W2520829703 creator A5029037860 @default.
• W2520829703 creator A5038304841 @default.
• W2520829703 creator A5038776015 @default.
• W2520829703 creator A5041408481 @default.
• W2520829703 creator A5050096645 @default.
• W2520829703 creator A5052884442 @default.
• W2520829703 creator A5069496168 @default.
• W2520829703 creator A5073606057 @default.
• W2520829703 creator A5075719435 @default.
• W2520829703 creator A5078882374 @default.
• W2520829703 creator A5088570028 @default.
• W2520829703 date "2016-09-15" @default.
• W2520829703 modified "2023-10-01" @default.
• W2520829703 title "N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms" @default.
• W2520829703 cites W1963479676 @default.
• W2520829703 cites W1968067487 @default.
• W2520829703 cites W1976678890 @default.
• W2520829703 cites W1983340150 @default.
• W2520829703 cites W1986425967 @default.
• W2520829703 cites W2004149548 @default.
• W2520829703 cites W2035477056 @default.
• W2520829703 cites W2037078651 @default.
• W2520829703 cites W2051999842 @default.
• W2520829703 cites W2067929856 @default.
• W2520829703 cites W2084009277 @default.
• W2520829703 cites W2084485820 @default.
• W2520829703 cites W2085360366 @default.
• W2520829703 cites W2089323877 @default.
• W2520829703 cites W2093700893 @default.
• W2520829703 cites W2126154566 @default.
• W2520829703 cites W2131823335 @default.
• W2520829703 cites W2131925003 @default.
• W2520829703 cites W2140606211 @default.
• W2520829703 cites W2141895509 @default.
• W2520829703 cites W2155988173 @default.
• W2520829703 cites W2156436903 @default.
• W2520829703 cites W2159977744 @default.
• W2520829703 cites W2166023752 @default.
• W2520829703 cites W2167116216 @default.
• W2520829703 cites W2182743676 @default.
• W2520829703 cites W240506283 @default.
• W2520829703 cites W3171418018 @default.
• W2520829703 cites W33021784 @default.
• W2520829703 cites W4232804908 @default.
• W2520829703 cites W53111918 @default.
• W2520829703 doi "https://doi.org/10.1186/s12888-016-1030-3" @default.
• W2520829703 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5024434" @default.
• W2520829703 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27629871" @default.
• W2520829703 hasPublicationYear "2016" @default.
• W2520829703 type Work @default.
• W2520829703 sameAs 2520829703 @default.
• W2520829703 citedByCount "34" @default.
• W2520829703 countsByYear W25208297032017 @default.
• W2520829703 countsByYear W25208297032018 @default.
• W2520829703 countsByYear W25208297032019 @default.
• W2520829703 countsByYear W25208297032020 @default.
• W2520829703 countsByYear W25208297032021 @default.
• W2520829703 countsByYear W25208297032022 @default.
• W2520829703 countsByYear W25208297032023 @default.
• W2520829703 crossrefType "journal-article" @default.
• W2520829703 hasAuthorship W2520829703A5001271340 @default.
• W2520829703 hasAuthorship W2520829703A5013936218 @default.
• W2520829703 hasAuthorship W2520829703A5022628011 @default.
• W2520829703 hasAuthorship W2520829703A5028782037 @default.
• W2520829703 hasAuthorship W2520829703A5029037860 @default.
• W2520829703 hasAuthorship W2520829703A5038304841 @default.
• W2520829703 hasAuthorship W2520829703A5038776015 @default.
• W2520829703 hasAuthorship W2520829703A5041408481 @default.
• W2520829703 hasAuthorship W2520829703A5050096645 @default.
• W2520829703 hasAuthorship W2520829703A5052884442 @default.
• W2520829703 hasAuthorship W2520829703A5069496168 @default.
• W2520829703 hasAuthorship W2520829703A5073606057 @default.
• W2520829703 hasAuthorship W2520829703A5075719435 @default.
• W2520829703 hasAuthorship W2520829703A5078882374 @default.
• W2520829703 hasAuthorship W2520829703A5088570028 @default.
• W2520829703 hasBestOaLocation W25208297031 @default.
• W2520829703 hasConcept C118552586 @default.
• W2520829703 hasConcept C126322002 @default.
• W2520829703 hasConcept C142724271 @default.
• W2520829703 hasConcept C15744967 @default.
• W2520829703 hasConcept C159110408 @default.
• W2520829703 hasConcept C168563851 @default.
• W2520829703 hasConcept C197934379 @default.
• W2520829703 hasConcept C204787440 @default.
• W2520829703 hasConcept C27081682 @default.
• W2520829703 hasConcept C2776412080 @default.
• W2520829703 hasConcept C2776921671 @default.
• W2520829703 hasConcept C2779727114 @default.
• W2520829703 hasConcept C2779951463 @default.
• W2520829703 hasConcept C2780135775 @default.
• W2520829703 hasConcept C2780494398 @default.
• W2520829703 hasConcept C2780864610 @default.
• W2520829703 hasConcept C2908647359 @default.
• W2520829703 hasConcept C535046627 @default.

• next